Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, P. R. China.
Pharmacy Institute and Department of Hepatology, Institute of Hepatology and Metabolic Diseases, Institute of Integrated Chinese and Western Medicine for Oncology, The affiliated Hospital of Hangzhou Normal University, College of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, P. R. China.
Exp Biol Med (Maywood). 2021 Jun;246(12):1343-1354. doi: 10.1177/15353702211008380. Epub 2021 Apr 25.
Cytokinesis, the final step of mitosis, is critical for maintaining the ploidy level of cells. Cytokinesis is a complex, highly regulated process and its failure can lead to genetic instability and apoptosis, contributing to the development of cancer. Human hepatocellular carcinoma is often accompanied by a high frequency of aneuploidy and the DNA ploidy pattern observed in human hepatocellular carcinoma results mostly from impairments in cytokinesis. Many key regulators of cytokinesis are abnormally expressed in human hepatocellular carcinoma, and their expression levels are often correlated with patient prognosis. Moreover, preclinical studies have demonstrated that the inhibition of key cytokinesis regulators can suppress the growth of human hepatocellular carcinoma. Here, we provide an overview of the current understanding of the signaling networks regulating cytokinesis, the key cytokinesis regulators involved in the initiation and development of human hepatocellular carcinoma, and their applications as potential diagnostic and therapeutic biomarkers.
有丝分裂的最后一步是细胞分裂,对于维持细胞的倍性水平至关重要。细胞分裂是一个复杂的、高度调控的过程,其失败会导致遗传不稳定性和细胞凋亡,从而促进癌症的发展。人肝癌常伴有高频率的非整倍体,人肝癌中观察到的 DNA 倍性模式主要是由于细胞分裂受损所致。许多细胞分裂的关键调节因子在人肝癌中异常表达,其表达水平常与患者的预后相关。此外,临床前研究表明,抑制关键细胞分裂调节因子可以抑制人肝癌的生长。在这里,我们概述了目前对调节细胞分裂的信号网络的理解,以及参与人肝癌发生和发展的关键细胞分裂调节因子,并探讨了它们作为潜在的诊断和治疗生物标志物的应用。